Inaktiver Wert

Andere Sprachen Guided Therapeutics Inc OTC Bulletin Board

Aktien

US40171F1057

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

28.03.	Guided Therapeutics, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Guided Therapeutics gibt den Abschluss der klinischen Studie für die chinesische Zulassung bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results	20.02.
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	20.11.
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	20.11.
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10.08.23
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval	01.05.23
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30.03.23
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)	30.03.23
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	30.03.23
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation	15.03.23
Guided Therapeutics, Inc. Announces CEO Changes	09.03.23
Guided Therapeutics, Inc. Announces Executive Changes	09.03.23
GUIDED THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)	09.03.23
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	21.12.22
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	21.12.22
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14.11.22
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14.11.22
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan	09.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Guided Therapeutics Inc OTC Bulletin Board

Aktien

US40171F1057

Andere Sprachen

Filter